Breast Cancer: More Frequent dosing Improves Results by 26%

At the last San Antonio Breast Cancer conference a study was presented with 2,005 women participants. These patients had breast cancer that had spread to the lymphnodes.

There were essentially two types of chemotherapy in the study, conventional and dose dense (more frequent) The group given the dose dense therapy did 26% better. This suggests an Advance in Adjuvant breast chemotherapy.

We will be following confirmatory studies closely.

Webmaster

March 03, 2003